Harvard Catalyst Profiles
Contact, publication, and social network information about Harvard faculty and fellows.
Home
About
Overview
Open Source Software
Help
History (1)
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.
See All Pages
Find People
Find Everything
Login
to
edit your profile
(add a photo, education, awards, etc.), search
student opportunities
, and
create reports
.
Edit My Profile
My Person List (
0
)
Opportunity Search
Return to Top
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study.
Epirubicin/paclitaxel/etoposide in extensive-stage small-cell lung cancer: a phase I-II study. Br J Cancer. 2006 May 08; 94(9):1263-6.
View in:
PubMed
subject areas
Aged
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Small Cell
Epirubicin
Etoposide
Female
Humans
Infusions, Intravenous
Injections, Intravenous
Lung Neoplasms
Male
Maximum Tolerated Dose
Middle Aged
Paclitaxel
Treatment Outcome
authors with profiles
Elizabeth Healey Baldini, M.D.